These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26033118)

  • 1. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
    Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
    J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
    Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
    Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
    Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
    BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
    Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
    Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
    Shen HG; Halbur PG; Opriessnig T
    J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
    Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR
    Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
    Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
    Oh Y; Seo HW; Park C; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.